What did we learn from the bictegravir switch studies?

被引：9
|
作者：
Harris, Marianne [1 ]
机构：
[1] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
来源：
LANCET HIV | 2018年 / 5卷 / 07期
关键词：
NON-INFERIORITY TRIAL; TENOFOVIR ALAFENAMIDE; INITIAL TREATMENT; DOUBLE-BLIND; EMTRICITABINE; DOLUTEGRAVIR; MULTICENTER; INHIBITORS; PHASE-3;
D O I：
10.1016/S2352-3018(18)30099-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E336 / E337
页数：2
相关论文
共 50 条
  • [1] What did we learn from 'omics' studies in osteoarthritis
    Ruiz-Romero, Cristina
    Rego-Perez, Ignacio
    Blanco, Francisco J.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (01) : 114 - 120
  • [2] What did we learn and what will we learn from hydrodynamics at RHIC?
    Kolb, PF
    INTERSECTIONS OF PARTICLE AND NUCLEAR PHYSICS, 2003, 698 : 694 - 697
  • [3] What did we learn from multiple omics studies in asthma?
    Ivanova, Olga
    Richards, Levi B.
    Vijverberg, Susanne J.
    Neerincx, Anne H.
    Sinha, Anirban
    Sterk, Peter J.
    Maitland-van der Zee, Anke H.
    ALLERGY, 2019, 74 (11) : 2129 - 2145
  • [4] What did we learn from Tamiflu?
    Dyer, Owen
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [5] What did we learn from this session?
    Pinto, L. Abegao
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [6] What did we teach; what did they learn?
    Pratt, Dan
    MEDICAL TEACHER, 2024, 46 (10) : 1378 - 1378
  • [7] The Asian crisis: what did we learn and when did we learn it?
    Grenville, Stephen
    ASIAN-PACIFIC ECONOMIC LITERATURE, 2017, 31 (02) : 30 - 44
  • [8] Studies on PA in schizophrenia: What did we learn? What is effective?
    de Girolamo, G.
    Bulgari, V.
    EUROPEAN PSYCHIATRY, 2016, 33 : S41 - S41
  • [9] What Did We Learn from Model Membrane Studies on Biological Membranes
    Lichtenberg, Dov A.
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 710A - 710A
  • [10] WHAT DID WE LEARN FROM DEEPWATER HORIZON?
    Viglione, Giuliana
    CHEMICAL & ENGINEERING NEWS, 2020, 98 (35) : 26 - +
12345